Pyrazole compound and therapeutic agent for diabetes comprising the same

Details for Australian Patent Application No. 2006250354 (hide)

Owner Japan Tobacco Inc.

Inventors Ozawa, Koichi; Sakata, Kaoru; Fukuda, Kenji; Ueda, Nobuhisa; Nakamura, Takeshi; Nomura, Yukihiro; Matsuda, Isamu; Takagi, Masaki

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006250354

PCT Pub. Number WO2006/126695

Priority 2005-367286 20.12.05 JP; 60/685,037 26.05.05 US; 2005-148847 23.05.05 JP; 60/755,820 03.01.06 US

Filing date 22 May 2006

Wipo publication date 30 November 2006

International Classifications

C07D 231/40 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4184 (2006.01)

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/454 (2006.01)

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4725 (2006.01)

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/53 - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/126695 Priority application(s): WO2006/126695

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006250359-Fuel cell system

2006250347-Agent for improvement of insulin resistance